Found 29 matching trials
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia PHASE3 This randomized phase III trial studies how well imatinib mesylate works in...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma PHASE3 This phase III trial compares the effect of adding levocarnitine to standar...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma PHASE2 This is a Phase II clinical trial testing the use of two antigen-directed t...
Show More Location
Novant Health Presbyterian Hemby Children's Hospital
Learn More & Join Trial
A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia PHASE1 The purpose of this study is to determine the safety and tolerability of re...
Show More Location
University of California, San Francisco (UCSF) Benioff Children's Hospital
Learn More & Join Trial
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia PHASE2 This phase II trial studies how well inotuzumab ozogamicin works in treatin...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Learn More & Join Trial
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) PHASE2 This phase II trial tests the safety and effectiveness of giving chemothera...
Show More Location
Multiple Locations
Learn More & Join Trial
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy PHASE3 This phase III trial studies whether inotuzumab ozogamicin added to post-in...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) PHASE2 This is a clinical trial testing whether the addition of one of two chemoth...
Show More Location
Rady Children's Hospital
Learn More & Join Trial
Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment PHASE2 This phase II trial tests how well adding revumenib to usual treatment (bli...
Show More Location
Multiple Locations
Learn More & Join Trial
CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) PHASE1 The purpose of the study is to evaluate the safety and tolerability of the ...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial